The Top 10 Pharma Drug Recalls: Time for Innovation
Posted: 08/08/2012 12:00:00 AM EDT | 6
|
|
Pfizer and Johnson & Johnson recently announced that they were going to stop the development of the Alzheimer’s drug, Bapineuzumab, which was designed to halt build-up of plaque in the brain of patients, because it failed in two late-stage clinical trials. It also failed to improve cognitive or functional performance compared with a placebo in certain patients.
In assocication w...
|
Contributor:
Niamh Madigan |
-
Data Management at McLaren Racing -
Regulatory Guidelines for Viral Safety -
Do Pharma Organisations do enough to encourage the e-patient? -
Case Study: Using an IVRS to Manage a Multi-Site Supply -
Clinical Trial Conference: Which Clinical Trial Conference to Go to? -
The Top 10 Pharma Drug Recalls: Time for Innovation -
Optimising the Development of Protein Formulations -
The Top 10 Biggest Pharmaceutical Companies: Who's Recruiting? -
Asia Focus: Top 5 Challenges around Pharmacovigilance -
Pharma IQ Reviews Innovation at the Top 10 Global Drug Companies Over the Last 15 Years
* = required.
|
Very informative..
|
Replies (0)|
|
Very informative..
|
|
nice article
|
|
|
nice article
|
|
|
Good analysis.
|
|
|
Nice summary, but it doesn´t help at all to understand what happened. Let alone find ways to minimize risk.
Possible questions unraised are:
'Was there any indication in previously available information pointing toward the undesired results?'
'Were the milestone evaluations and decisions appropriate given the available information?'
'How many of these results were actually unavoidable (i.e. unforeseeable), and are consequently the natural economic (and sometimes patient) risk of any pharma innovator?'
'Are there any methods or strategies that have a proven track record of actually decreasing risk?'
Best regards
Renald Hennig, M.D.
|
-
Use of Cardiac Safety Data in Early Phase Trials to Supplement or Replace a Thorough QT Trial
June 11, 2012
Register Now -
Taking EDC to the next level: Moving from point solutions to an eClinical ecosystem
April 4, 2013
Register Now -
Adverse Event Reporting Online Training Course 2011
August 3, 2011
Register Now -
Protecting your Pharma Intellectual Property during Out-Licensing
February 7, 2013
Register Now
|
Reach Pharma professionals through cost-effective marketing opportunities to deliver your message, position yourself as a thought leader, and introduce new products, techniques and strategies to the market.
Learn More >> Learn how to sponsor a webinar with us? Join today and interact with a vibrant network of pharma professionals, keeping up to date with the pharma industry by accessing our wealth of Pharma articles, videos, online seminars, live conferences and more. Sign Up Today! |
| Pharma IQ, a division of IQPC 2013 All rights reserved. Use of this site constitutes acceptance of our User Agreement and Privacy Policy. Careers With IQPC | Contact Us | Unsubscribe to Bizo | About Us | Cookie Policy |
|
Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!